107 related articles for article (PubMed ID: 10667347)
1. Evaluation of the pharmacological activity of the pure cysteinyl-leukotriene receptor antagonists CGP 45715A (iralukast) and CGP 57698 in human airways.
Capra V; Ravasi S; Bolla M; Viappiani S; Pagliardini S; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Adv Exp Med Biol; 1999; 469():313-8. PubMed ID: 10667347
[No Abstract] [Full Text] [Related]
2. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.
Capra V; Bolla M; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Br J Pharmacol; 1998 Feb; 123(3):590-8. PubMed ID: 9504401
[TBL] [Abstract][Full Text] [Related]
3. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
4. Cysteinyl-leukotriene D(4) receptors in smooth muscle cells.
Bouchelouche K; Horn T; Nordling J; Larsen S; Hald T
Urology; 2001 Jun; 57(6 Suppl 1):109. PubMed ID: 11378074
[No Abstract] [Full Text] [Related]
5. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
6. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of a glucocorticosteroid, theophylline and the peptido-leukotriene-antagonist CGP 45715A on antigen-induced early and late phase airway response and inflammatory cell influx in sensitised guinea pigs.
Heuer HO; Leon I; Anderson GP; Jennewein HM
Eur J Pharmacol; 1999 Mar; 369(2):225-31. PubMed ID: 10206183
[TBL] [Abstract][Full Text] [Related]
8. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion.
Profita M; Sala A; Bonanno A; Siena L; Ferraro M; Di Giorgi R; Montalbano AM; Albano GD; Gagliardo R; Gjomarkaj M
J Pharmacol Exp Ther; 2008 Jun; 325(3):1024-30. PubMed ID: 18305014
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
11. CGP 45715 A: a leukotriene D4 analogue with potent peptido-LT antagonist activity.
Bray MA; Anderson WH; Subramanian N; Niederhauser U; Kuhn M; Erard M; von Sprecher A
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():503-7. PubMed ID: 1825370
[No Abstract] [Full Text] [Related]
12. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW
Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls.
Tufvesson E; Nihlberg K; Westergren-Thorsson G; Bjermer L
Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):67-73. PubMed ID: 21596548
[TBL] [Abstract][Full Text] [Related]
14. Modulation of leukotriene D4 attenuates the development of seizures in mice.
Rehni AK; Singh TG
Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):97-106. PubMed ID: 21641195
[TBL] [Abstract][Full Text] [Related]
15. Regulation of monocyte chemoattractant protein 1 by cysteinyl leukotriene D4 in human lung epithelial A549 cells.
Kim SH; Yang EM; Kim SH; Park HS
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):358-9. PubMed ID: 19852204
[No Abstract] [Full Text] [Related]
16. The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
Bouchelouche K; Andersen L; Nordling J; Horn T; Bouchelouche P
J Urol; 2003 Aug; 170(2 Pt 1):638-44. PubMed ID: 12853847
[TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential vanilloid 4 activation constricts the human bronchus via the release of cysteinyl leukotrienes.
McAlexander MA; Luttmann MA; Hunsberger GE; Undem BJ
J Pharmacol Exp Ther; 2014 Apr; 349(1):118-25. PubMed ID: 24504097
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous effect of leucotriene CysLT1 receptor antagonists on antigen-induced motor and inflammatory responses in guinea-pig airways.
Alfieri AB; Tramontana M; Cialdai C; Lecci A; Giuliani S; Crea A; Manzini S; Maggi CA
Auton Autacoid Pharmacol; 2007 Jan; 27(1):39-46. PubMed ID: 17199874
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
20. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
